At last, Advent’s official bid for Stada: €58 per share (€3.6bn)

German pharmaceutical group Stada informed the stock-market regulatory authorities it has received a binding offer by investor Advent International, which has valued the Bad Vilbel-based company approximately €3.6bn in cash, which equals €58 per share. Advent has also offered to pay dividend 2016, which amount to €0.7 per share. Advent’s offer is limited until Monday, February 27, 2017. Stada had already received in mid-February a €56/share bid by British investor Civent .
(Source Merkur)